Positives - Cash flow is ok - Guidance unchanged, EBIT positive for 2023 - Trading at 41% of book with strong balance sheet (accounts for the dividend paid)
Negatives - Q2 won't be any better - $700M charge in Q2 from the $6.4 dividend paid in April. - No dividend paid in Q1
Perhaps it will trade in the $14 - $16 range for a while? We should see $20+ later this year if/when things improve.
I have a target of $15.20 and $16.20 for my call options.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.